PRESS RELEASE
News
-
-
PRESS RELEASE
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
Qfitlia (fitusiran) approved as the first US therapy for hemophilia A or B with or without inhibitors, offering consistent protection with few injections, using unique mechanism to reduce bleeding episodes -
PRESS RELEASE
Sword Group : Notice of Convocation to the Shareholders for the Ordinary and Extraordinary General Meeting of the Company on April 28 2025
Notice to shareholders of Sword Group SE for Ordinary and Extraordinary General Meeting on April 28, 2025, including agenda, voting procedures, and shareholder rights -
-
-
-
-
PRESS RELEASE
D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq:IVP) in Connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Inspire Veterinary Partners, Inc. announces closing of securities purchase agreement for $2.0 million. Proceeds to be used for working capital and potential acquisitions -
-
